- Home
- About
- 🤖 AskAnzal AI Advisor
- 📅 Book a Call
- Your Account
- My AskAnzal Account
Over 2,000 real rulings — analysed for what they mean to your team. Published every day.
Showing 1914 cases
An oncologist complained about a joint AstraZeneca/MSD ovarian cancer advisory board. Most allegations were not upheld, but taking identifiable photos of HCPs…
Complaint alleged Bayer-commissioned ‘Guidelines in Practice’ videos were disguised promotion for Xarelto. Panel found sponsorship and PI links were clear; no breach…
Anonymous UK health professional complained Avamys banner ad on Pulse made the generic name illegible. Panel found breaches of Clauses 4.3 and…
Complaint alleged a third-party email linked GSK-sponsored COPD therapy reviews to “client product/therapy priorities”. Panel and Appeal Board had concerns about the…
Employee alleged an ECR Vienna ‘round table’ was really a dinner to gain favour and raised concerns about ‘grey areas’ culture and…
Complaint alleged Neupro online prescribing info was out of date and omitted rhabdomyolysis. Panel found the page was an internal test URL…
Complaint alleged a senior exec’s LinkedIn post (and UK staff ‘likes’) promoted an unlicensed COVID-19 vaccine to the public. Appeal Board found…
A UK employee accidentally ‘liked’ a global Menarini LinkedIn post about positive early data for an investigational AML compound. Panel said this…
Novartis-funded third‑party “medical education” videos were ruled promotional for unlicensed inclisiran, lacked clear sponsorship disclosure and certification, and breached multiple Code clauses…
Complaint alleged GSK promoted unlicensed products to the public via LinkedIn posts about Phase 3 RSV and Covid-19 antibody trials. Panel ruled…
Complaint about Lundbeck’s UK corporate website linking to global pages and alleged lack of reapproval. Panel found no promotion/public access breach, but…
Complaint about Leo executives’ online interviews on pharmaboardroom.com (UK-registered publisher). Panel/Appeal Board found the material was not promotional to UK audiences; no…
A senior AstraZeneca employee’s LinkedIn post linking to a vaccine efficacy press release, amplified by UK staff ‘likes’, was ruled promotion of…
BMJ ad framed as an acquisition announcement for Dificlir was ruled promotional. It lacked prescribing information and an adverse event reporting statement,…
Anonymous complaint alleged excessive rep calls, lack of SOP guidance and uncertified virtual materials (Jul 2020–Jun 2021). Panel found complainant didn’t meet…
Anzal, our PMCPA rulings expert, has knowledge of over 2,000 published cases — ask about precedents, clauses, and how they apply to your situation.
One real case. One key lesson. Every week — free.